Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents.
Eur J Med Chem
; 214: 113244, 2021 Mar 15.
Article
in En
| MEDLINE
| ID: mdl-33581551
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidines
/
Drug Design
/
Cyclin-Dependent Kinase 9
/
Protein Kinase Inhibitors
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Eur J Med Chem
Year:
2021
Type:
Article
Affiliation country:
United kingdom